Skip to main content
Premium Trial:

Request an Annual Quote

Nuclea, Clark to Use New Compute Cluster to Support Proteomic and Metabolomic Center

Premium

Nuclea Biotechnologies and Clark University will use a compute cluster installed earlier this year on the Clark campus to support a planned proteomic and metabolomic center.

The new center, which the partners announced this week, will offer bioinformatics resources that will allow the partners to analyze, identify, and quantify molecular targets as part of their biomedical research, clinical diagnostic discovery, and drug development efforts.

In addition to bioinformatics capabilities, the new center will also provide sample preparation equipment, gas and liquid chromatography and mass spectrometry instruments, and nuclear magnetic resonance facilities, Nuclea said.

Clark University was one of three institutions selected by the Pittsfield, Mass.-based firm to house new clusters aimed at providing resources for regional educational research as well as to boost its in-house compute capabilities (BI 04/08/2011).

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.